ALDH3A1 and hepatocellular carcinoma: In recent years, ALDH3A1 has been shown to be upregulated in several cancer types, for example, GC,101 lung cancer,189, 190 HCC,191 colon cancer,192 PCa193 and can be used as a biomarker to predict poor clinical outcomes.